MedPath

Cytosite Biopharma Inc.

Cytosite Biopharma Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2022-03-17
Last Posted Date
2023-08-09
Lead Sponsor
Cytosite Biopharma Inc.
Target Recruit Count
6
Registration Number
NCT05285696
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

Phase 1
Recruiting
Conditions
Solid Tumor, Unspecified, Adult
Lymphoma
Interventions
Drug: Single Arm
First Posted Date
2019-11-19
Last Posted Date
2024-02-20
Lead Sponsor
Cytosite Biopharma Inc.
Target Recruit Count
30
Registration Number
NCT04169321
Locations
🇨🇳

Chang-Gung Memorial Hospital, Taoyuan City, Guishan, Taiwan

🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath